VP of Operations
Dr. Riazifar has worked on stem cells and on exosomes, a subclass of stem cell derived extracellular vesicles since 2011. During his Ph.D. studies at the Stem Cell Research Center at the University of California Irvine, he pioneered a cell-free exosome-based approach to treat Multiple Sclerosis. At City of Hope, he was part of a clinical translation team initiating the world’s first clinical trial using stem cell exosomes for the treatment of type I diabetes.
Dr. Riazifar has extensive experience in manufacturing and characterizing pharmaceutical-grade exosomes, and has developed numerous exosomal based drug modalities, and been involved in multiple IND-enabling preclinical studies. He has published numerous high-impact articles on stem cells and stem cell-derived exosomes, and has consulted for many regenerative medicine companies. Dr. Riazifar received his Ph.D. in pharmaceutical sciences from UC Irvine.